Reduced expression of CD109 in tumor-associated endothelial cells promotes tumor progression by paracrine interleukin-8 in hepatocellular carcinoma
Open Access
- 18 April 2016
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (20) , 29333-29345
Abstract
Reduced expression of CD109 in tumor-associated endothelial cells promotes tumor progression by paracrine interleukin-8 in hepatocellular carcinomaKeywords
This publication has 46 references indexed in Scilit:
- AIP1 Expression in Tumor Niche Suppresses Tumor Progression and MetastasisCancer Research, 2015
- CD109 attenuates TGF-β1 signaling and enhances EGF signaling in SK-MG-1 human glioblastoma cellsBiochemical and Biophysical Research Communications, 2015
- Macrophage-secreted IL-8 induces epithelial-mesenchymal transition in hepatocellular carcinoma cells by activating the JAK2/STAT3/Snail pathwayInternational Journal of Oncology, 2014
- Using multiple cytokines to predict hepatocellular carcinoma recurrence in two patient cohortsBritish Journal of Cancer, 2013
- Microenvironmental regulation of tumor progression and metastasisNature Medicine, 2013
- Prognostic Value of CD109+ Circulating Endothelial Cells in Recurrent Glioblastomas Treated with Bevacizumab and IrinotecanPLOS ONE, 2013
- The perivascular niche regulates breast tumour dormancyNature Cell Biology, 2013
- Elevated Serum IL-8 Is Associated with the Presence of Hepatocellular Carcinoma and Independently Predicts SurvivalCancer Investigation, 2012
- Genes that Distinguish Physiological and Pathological AngiogenesisCancer Cell, 2007
- P48 is a predictive marker for outcome of postoperative interferon‐α treatment in patients with hepatitis B virus infection‐related hepatocellular carcinomaCancer, 2006